Tag: Cardiovascular Systems

First patients treated in United States with OrbusNeich Teleport Microcatheter

The first patients in the United States have been treated using the OrbusNeich Teleport Microcatheter (Teleport; Cardiovascular Systems), which recently received US Food and...

First European patients treated with Peripheral Orbital atherectomy system

The first patients in Germany have been treated with the Stealth 360 Peripheral Orbital Atherectomy System (OAS; Cardiovascular Systems Inc). The German cases represent...

Cardiovascular Systems signs international distribution agreement with OrbusNeich

Cardiovascular Systems, Inc. (CSI) has signed an exclusive international distribution agreement with OrbusNeich to sell its coronary and peripheral orbital atherectomy systems (OAS) outside...

First patients treated with new peripheral orbital atherectomy device

Cardiovascular Systems, a medical device company developing and commercialising  interventional treatment systems for peripheral and coronary artery disease, announced today that the first patients were...

Cardiovascular Systems announces partnerships with OrbusNeich and Integer

Cardiovascular Systems (CSI) has announced two new partnerships broadening the company’s product portfolio. According to a company release, CSI is now the exclusive US...

Lesion preparation using Diamondback 360 orbital atherectomy enhances paclitaxel distribution in...

CBSET, a not-for-profit preclinical research institute dedicated to translational research, education, and advancement of medical technologies, has announced that its scientists have published data...

Lasting benefits following endovascular intervention in critical limb ischaemia

One-year data from Cardiovascular System’s all-comers LIBERTY 360 clinical study have demonstrated sustained benefits following endovascular intervention in critical limb ischaemia patients. The data were...

LIBERTY 360 degrees sub-analysis shows high freedom from adverse events with...

A new sub-analysis from Cardiovascular System’s LIBERTY 360 study supports the use of the company’s Diamondback 360 peripheral orbital atherectomy system (OAS) during endovascular...

Study demonstrates sustained benefit of endovascular intervention in patients with lower...

Cardiovascular systems (CSI) presented six-month data from its LIBERTY 360 degrees post-market study in a presentation at the 29th International Symposium on Endovascular Therapy...